Sculptor Capital LP Esperion Therapeutics, Inc. Put Options Transaction History

Sculptor Capital LP

  • $2.76 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$4.81 - $11.92 $639,249 - $1.58 Million
-132,900 Reduced 74.08%
46,500 $233,000
Q3 2020

Nov 12, 2020
BUY
$31.18 - $52.71 $1.44 Million - $2.43 Million
46,100 Added 34.58%
179,400 $6.67 Million
Q2 2020

Aug 14, 2020
BUY
$30.04 - $51.31 $2.21 Million - $3.78 Million
73,600 Added 123.28%
133,300 $6.84 Million
Q2 2018

Aug 13, 2018
BUY
$36.2 - $76.4 $2.16 Million - $4.56 Million
59,700 New
59,700 $2.34 Million

Others Institutions Holding ESPR

# of Institutions
208
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $160M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email